Diabetes and fatty liver: Involvement of incretin and its benefit for fatty liver management

doi:10.4239/wjd.v14.i5.549

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3661)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

183

WORD

HTML

2198

Figures (1-3)

389

Tables (1-1)

289

Sum=3085

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

174

Download

404

Sum=578

May 15, 2023 (publication date) through Nov 23, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Diabetes. May 15, 2023; 14(5): 549-559
Published online May 15, 2023. doi: 10.4239/wjd.v14.i5.549

Full Size Figure Download Figure

Figure 3 The effect of type 2 diabetes mellitus on incretin hormone and the development of non-alcoholic fatty liver disease. Increased body weight as the result of reduced incretin effects leads to adipose tissue insulin resistance, increased lipolysis and leptin, and decreased adiponectin, resulting in hepatic fat deposition. DM: Diabetes Mellitus; DNL: De novo lipogenesis; FFA: Free fatty acids; TG: Triglycerides.

Citation: Wibawa IDN, Mariadi IK, Somayana G, Krisnawardani Kumbara CIY, Sindhughosa DA. Diabetes and fatty liver: Involvement of incretin and its benefit for fatty liver management. World J Diabetes 2023; 14(5): 549-559
URL: https://www.wjgnet.com/1948-9358/full/v14/i5/549.htm
DOI: https://dx.doi.org/10.4239/wjd.v14.i5.549